NICOLE JOHNSON: Open Payments
NPI 1053974360 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 33 payments from 12 companies in 2025. Trend: 2023 $467 · 2024 $637 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $199 |
| ABBVIE INC. | 7 | $194 |
| PFIZER INC. | 4 | $76 |
| Grifols USA, LLC | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Impel Pharmaceuticals LLC | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| CSL Behring | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
Products named: Wegovy, QULIPTA, UBRELVY, NURTEC ODT, Gamunex-C, AJOVY, Rybelsus, TRUDHESA.
Industry payments across CA — which companies pay providers there.
